Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

120 results about "Aconitic acid" patented technology

Aconitic acid is an organic acid. The two isomers are cis-aconitic acid and trans-aconitic acid. The conjugate base of cis-aconitic acid, cis-aconitate is an intermediate in the isomerization of citrate to isocitrate in the citric acid cycle. It is acted upon by the enzyme aconitase.

Multifunctional foaming composition with wettability modifying, corrosion inhibitory and mineral scale inhibitory/dispersants properties for high temperature and ultra high salinity

The present invention is related to the obtaining and using of multifunctional foaming compositions with wettability modifying, corrosion inhibitory and inhibitory/dispersants mineral scale properties with high stability in environments of high temperature, high pressure and tolerance to high concentrations of divalent ions such as calcium, magnesium, strontium and barium. The multifunctional foaming compositions are obtained from the combination of supramolecular complexes resulting from interactions of alkyl amido propyl hydroxysultaines and/or alkyl amido propyl betaines and/or alkyl hydroxysultaines and/or alkyl betaines and anionic surfactant of type alkyl hydroxyl sodium sulfonate and alkenyl sulphonates of sodium, with cationic surfactants as tetra-alkyl ammonium halides and copolymers derivatives of itaconic acid/sodium vinyl sulfonate and/or terpolymers derived from itaconic acid/sodium vinyl sulphonate/aconitic acid. These multinational foaming compositions control the gas channeling and favorably change the wettability and increase the recovery factor of crude oil in naturally fractured reservoirs of carbonate type and heterogeneous lithology. In addition to this, the multifunctional foaming compositions of this invention exhibit anti-corrosive properties in typical environments of production tubing of crude oil and antifouling/dispersants of mineral salts as calcium carbonate, calcium sulfate, barium and strontium in the reservoir and in the production and injection pipelines.
Owner:INST MEXICANO DEL GASOLINEEO

A green synthesis method for carbon quantum dot bonded silica gel chromatography filler

This invention has discloses a green synthesis method for carbon quantum dot bonded silica gel chromatography filler, which comprises the concrete steps of: mixing the solid powder of aconitic acid and tryptophan to be ground evenly, letting the mixture react under the temperature of 180oC- 200oC for 3 - 6 hours. Through dissolution, centrifugation and freeze drying of the generated solid, the amino-functionalized carbon quantum dots (NCDs) are obtained; After that, NCDs are dispersed in DES and added with gamma-glycidoxypropyl trimethoxy siloxane(GPTMS). Under the protection of N2 and the temperature of 55oC- 65oC, the mixture is stirred to react for 22 - 25 hours, then the silica gel (SiO2) is added to react for another 12 - 48 hours. Water and absolute ethyl alcohol are alternatively used to wash the raw product generated from the reaction. Silica gel chromatography filler modified by carbon quantum dots will be generated after drying. This green synthesis method realizes the surface bond of carbon quantum dots and silica gel through epoxy group and amino. DES used in the process of reaction is reaction solvent, which serves as an excellent dispersing agent for carbon quantum dots and silica gel, ensures higher bonded amount, and at the same time, meets the requirements of green chemistry.
Owner:LANZHOU INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Polycarboxylic acid-series water reducing agent with ultrahigh water absorbing capacity and preparation method and use method thereof

The invention discloses a polycarboxylic acid-series water reducing agent with ultrahigh water absorbing capacity and a preparation method and a use method thereof, belonging to the technical field of building materials. The water reducing agent consists of the following raw materials in parts by weight: 100 parts of unsaturated polyether (I), 10-18 parts of acrylic acid, 1-3 parts of acrylamide,1.25-9.25 parts of aconitic acid, 0.45-2.25 parts of hydrogen peroxide, 0.15-0.75 part of L-ascorbic acid, 0.12-0.48 part of mercaptoacetic acid, 0.12-0.48 part of mercaptopropionic acid, 6-10 parts of sodium hydrate and 125-195 parts of water. The invention provides a polycarboxylic acid-series water reducing agent having the advantages of simple process, convenience for operating, low raw material cost and ultrahigh water absorbing capacity, a preparation method and a use method. Self-made unsaturated polyether (I) DD-405 is used for replacing methyl allyl polyethenoxy ether, so that the raw material supply market of the polycarboxylic acid-series water reducing agent is expanded, raw material cost is reduced, and raw material price is stabilized. The polycarboxylic acid-series water reducing agent is suitable for construction projects of high-rise buildings, large-span bridges, marine drilling platforms, tunnels, dams and airports.
Owner:SHANGHAI DONGDA CHEM

Chitosan oligosaccharide fatty acid grafting-adriamycin bonded drug, preparation and applications

The invention provides a chitosan oligosaccharide fatty acid grafting-adriamycin bonded pro-drug, which is prepared by the following steps of: dissolving doxorubicin hydrochloride into dimethyl sulfoxide, adding ethylamine to stir and dissolving the product into naphthyridine; then dissolving cis-aconitic acid anhydride into oxetone and dropping into adriamycin solution, stirring, extracting, and centrifugating to disperse the deposits into water, freezing and drying to obtain an adriamycin- cis-aconitic acid midbody; dissolving chitosan oligosaccharide fatty acid grafting into water, additionally taking the theadriamycin-cis-aconitic acid midbody and dripping the dimethyl sulfoxide liquid, dropping into the grafting agueous solution, stirring, dialyzing, freezing and drying, thus obtaining the chitosan oligosaccharide fatty acid grafting-adriamycin bonded pro-drug; wherein the molecular weight of chitosan oligosaccharide is between 1 and 200 kDa; the deacetylation is between 70 and 100 percent; the carbon chain length of the fatty acid is between C12 and C22; and the substitution degree of the amino group is between 1 and 50 percent. The adriamycin after bonded with the chitosan oligosaccharide fatty acid grafting has remarkable antitumor curative property, can reverse the drug tolerance of tumor cells and can be applied for preparing the antitumor drugs and the drugs which can reverse the drug tolerance of tumor cells.
Owner:ZHEJIANG UNIV

Multifunctional foaming composition with wettability modifying, corrosion inhibitory and mineral scale inhibitory/dispersants properties for high temperature and ultra high salinity

The present invention is related to the obtaining and using of multifunctional foaming compositions with wettability modifying, corrosion inhibitory and inhibitory / dispersants mineral scale properties with high stability in environments of high temperature, high pressure and tolerance to high concentrations of divalent ions such as calcium, magnesium, strontium and barium. The multifunctional foaming compositions are obtained from the combination of supramolecular complexes resulting from interactions of alkyl amido propyl hydroxysultaines and / or alkyl amido propyl betaines and / or alkyl hydroxysultaines and / or alkyl betaines and anionic surfactant of type alkyl hydroxyl sodium sulfonate and alkenyl sulphonates of sodium, with cationic surfactants as tetra-alkyl ammonium halides and copolymers derivatives of itaconic acid / sodium vinyl sulfonate and / or terpolymers derived from itaconic acid / sodium vinyl sulphonate / aconitic acid. These multinational foaming compositions control the gas channeling and favorably change the wettability and increase the recovery factor of crude oil in naturally fractured reservoirs of carbonate type and heterogeneous lithology. In addition to this, the multifunctional foaming compositions of this invention exhibit anti-corrosive properties in typical environments of production tubing of crude oil and antifouling / dispersants of mineral salts as calcium carbonate, calcium sulfate, barium and strontium in the reservoir and in the production and injection pipelines.
Owner:INST MEXICANO DEL GASOLINEEO

Methods for preparing graphene dispersant and graphene/raw paint composite anti-corrosive coating

InactiveCN107964103ADisperse fastDispersion effectively makes graphene uniformNatural resin coatingsAnti-corrosive paintsAconitic acidOrganic solvent
The invention discloses methods for preparing a graphene dispersant and a graphene/raw paint composite anti-corrosive coating. The method for preparing the graphene dispersant comprises adding sodiumlignosulphonate, ammonium persulfate and deionized water into a reaction container, carrying out stirring so that the sodium lignosulfonate is fully dissolved, adding trans-1, 2, 3-aconitic acid and acrylamide into the solution for a reaction, then cooling the reaction solution to the room temperature, adding an organic solvent into the reaction solution drop by drop to separate solid precipitates, filtering the solid precipitates to obtain a crude product, and purifying and drying the crude product to obtain the graphene dispersant. The method for preparing the graphene/raw paint composite anti-corrosive coating comprises dissolving the graphene dispersant in water, carrying out ultrasonic treatment for full dissolution, adjusting pH to greater than 7, adding graphene into the solution, carrying out uniform ultrasonic mixing to obtain a graphene dispersion liquid, adding the graphene dispersion liquid into raw paint and carrying out uniform stirring to obtain the graphene/raw paint composite anti-corrosive coating.
Owner:FUJIAN NORMAL UNIV

Glucan-containing pharmaceutical composition and preparation method thereof

The invention discloses a glucan-containing pharmaceutical composition which comprises glucan-polyethyleneimine and a pharmaceutically active component activated by cis-aconitic acid anhydride. Glucan and polyethyleneimine are bonded through urethane bonds, cis-aconitic acid anhydride and the pharmaceutically active component are bonded through amide bonds, and the pharmaceutically active component activated by cis-aconitic acid anhydride and glucan-polyethyleneimine are bonded through amide bonds which are jointed between cis-aconitic acid anhydride and polyethyleneimine. After entering a human body, the glucan-containing pharmaceutical composition forms a shell-core structure, can not be identified by the reticuloendothelial system, and gradually concentrates at the site of a tumor mass. Under the acidic conditions of the tumor site, the amide bonds between the pharmaceutically active component activated by cis-aconitic acid anhydride and polyethyleneimine are broken to release a large amount of the pharmaceutically active component, while the release of the pharmaceutically active component at other sites is extremely low, thus, the toxicity to the health cells is reduced, and the toxic or side effect is reduced. The invention discloses a preparation method of the glucan-containing pharmaceutical composition mentioned above.
Owner:SHENZHEN INST OF ADVANCED TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products